F. Árias

1.7k total citations
87 papers, 1.2k citations indexed

About

F. Árias is a scholar working on Clinical Psychology, Psychiatry and Mental health and Epidemiology. According to data from OpenAlex, F. Árias has authored 87 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Clinical Psychology, 24 papers in Psychiatry and Mental health and 21 papers in Epidemiology. Recurrent topics in F. Árias's work include Substance Abuse Treatment and Outcomes (18 papers), Schizophrenia research and treatment (12 papers) and Cannabis and Cannabinoid Research (12 papers). F. Árias is often cited by papers focused on Substance Abuse Treatment and Outcomes (18 papers), Schizophrenia research and treatment (12 papers) and Cannabis and Cannabinoid Research (12 papers). F. Árias collaborates with scholars based in Spain, United States and Mexico. F. Árias's co-authors include Ignacio Basurte-Villamor, Pablo Vega, Néstor Szerman, Antoni Gual, Consuelo Morant, Joan Trujols, Jordi Sanahuja, Miguel Casas, Lídia Segura and Rubén A. Quintero and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

F. Árias

78 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Árias Spain 18 301 270 246 221 219 87 1.2k
Patrik Sobocki Sweden 19 105 0.3× 218 0.8× 300 1.2× 160 0.7× 56 0.3× 44 1.5k
Charles P. Lewis United States 20 128 0.4× 75 0.3× 209 0.8× 176 0.8× 105 0.5× 43 1.2k
Daniel N. Masica United States 14 76 0.3× 336 1.2× 249 1.0× 198 0.9× 234 1.1× 23 1.1k
Eylem Şahin Cankurtaran Türkiye 21 79 0.3× 60 0.2× 275 1.1× 98 0.4× 278 1.3× 40 1.1k
Kathleen M. Grant United States 18 227 0.8× 99 0.4× 104 0.4× 140 0.6× 80 0.4× 47 1.0k
K. Mcdermott United States 16 238 0.8× 97 0.4× 68 0.3× 150 0.7× 491 2.2× 52 1.2k
Suzanne Penna United States 11 222 0.7× 127 0.5× 334 1.4× 336 1.5× 267 1.2× 24 1.8k
L. Randolph Waid United States 13 490 1.6× 105 0.4× 266 1.1× 177 0.8× 65 0.3× 19 1.4k
A. L. Johnson United Kingdom 19 158 0.5× 234 0.9× 1.2k 4.7× 314 1.4× 94 0.4× 40 2.6k
Maher Karam‐Hage United States 19 130 0.4× 79 0.3× 78 0.3× 107 0.5× 212 1.0× 60 1.2k

Countries citing papers authored by F. Árias

Since Specialization
Citations

This map shows the geographic impact of F. Árias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Árias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Árias more than expected).

Fields of papers citing papers by F. Árias

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Árias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Árias. The network helps show where F. Árias may publish in the future.

Co-authorship network of co-authors of F. Árias

This figure shows the co-authorship network connecting the top 25 collaborators of F. Árias. A scholar is included among the top collaborators of F. Árias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Árias. F. Árias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Árias, F., et al.. (2024). Divergent Roles of APOAI and APOM in the Identification of Alcohol Use Disorder and Their Association With Inflammation and Cognitive Decline: A Pilot Study. The International Journal of Neuropsychopharmacology. 27(7). 1 indexed citations
4.
Árias, F., et al.. (2024). Rheumatoid meningitis: a case series report and review of modern therapeutic schemes and outcome. Neurological Sciences. 45(12). 5875–5887.
5.
6.
Folgar, Manuel Isorna, et al.. (2022). Impacto de la legalización del consumo recreativo del cannabis. Adicciones. 35(3). 349–376. 6 indexed citations
7.
Szerman, Néstor, F. Árias, Jaime Algorta, et al.. (2021). Effectiveness of tianeptine in patients with major depressive disorder and substance use disorder.. PubMed. 49(4). 135–144. 1 indexed citations
8.
López‐Pelayo, Hugo, David Nutt, Chrysanthi Blithikioti, et al.. (2020). The blind men and the elephant: Systematic review of systematic reviews of cannabis use related health harms. European Neuropsychopharmacology. 33. 1–35. 84 indexed citations
9.
Folgar, Manuel Isorna, et al.. (2020). Cannabis terapéutico y COVID-19: entre el oportunismo y la infoxicación. Adicciones. 32(3). 167–172. 13 indexed citations
10.
Giraldo, Luís Fernando Garcés, et al.. (2019). Cultura escolar, profesionalidad pedagógica y trayectos biográfico-profesionales: sobre el estudio cualitativo en Norte y Suroeste de Antioquia (Colombia). Revista ESPACIOS. 40(39). 1 indexed citations
11.
Mesı́a, Ricard, A. Rueda, Ruth Vera, et al.. (2012). Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial. Annals of Oncology. 24(2). 448–453. 23 indexed citations
12.
13.
14.
González-Martı́n, Antonio, E. Fernández, María Ángeles Vaz Salgado, et al.. (2007). Long-term outcome of a phase II study of weekly docetaxel with a short course of estramustine and enoxaparine in hormone-resistant prostate cancer patients. Clinical & Translational Oncology. 9(5). 323–328. 2 indexed citations
15.
Sáiz-Ruiz, Jerónimo, Ángela Ibáñez, Marina Díaz‐Marsá, et al.. (2002). Efficacy of venlafaxine in major depression resistant to selective serotonin reuptake inhibitors. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 26(6). 1129–1134. 32 indexed citations
16.
Árias, F., et al.. (2002). Consumo de drogas y riesgo de recaída en la esquizofrenia. Psiquiatría Biológica. 9(2). 63–67. 1 indexed citations
17.
Árias, F., et al.. (2000). Disfunciones sexuales inducidas por los inhibidores de la recaptación de serotonina. Atención Primaria. 26(6). 389–394. 8 indexed citations
18.
Árias, F., et al.. (1998). Comparative efficacy and tolerability among different selective serotonin re-uptake inhibitors and venlafaxine in a naturalistic setting. International Journal of Psychiatry in Clinical Practice. 2(4). 255–260. 5 indexed citations
19.
Quintero, Rubén A., Mark P. Johnson, Roberto Romero, et al.. (1995). In-utero percutaneous cystoscopy in the management of fetal lower obstructive uropathy. The Lancet. 346(8974). 537–540. 119 indexed citations
20.
Mangado, Enriqueta Ochoa, et al.. (1993). Deshabituación con naltrexona en la dependencia de opiaceos: un estudio evolutivo. Revista Española de Drogodependencias. 18(4). 233–246. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrik Sobocki Breakdown of academic impact, for papers by Charles P. Lewis Breakdown of academic impact, for papers by Daniel N. Masica Breakdown of academic impact, for papers by Eylem Şahin Cankurtaran Breakdown of academic impact, for papers by Kathleen M. Grant Breakdown of academic impact, for papers by K. Mcdermott Breakdown of academic impact, for papers by Suzanne Penna Breakdown of academic impact, for papers by L. Randolph Waid Breakdown of academic impact, for papers by A. L. Johnson Breakdown of academic impact, for papers by Maher Karam‐Hage
Rankless by CCL
2026